Business ❯Companies

Biotechnology

Genetic Testing Moderna Genetics Scorpius Holdings Inc Samsung Biologics Bolt Biotherapeutics Consumer Genetics AlloVir Inc.

Wojcicki’s Nonprofit Tops Regeneron With $305M Bid for 23andMe

The sale now hinges on bankruptcy court approval after 27 states sued to block the transfer of customer genetic data.

South Korea Prepares for High-Stakes Tariff Negotiations in Washington

23andMe Faces Bankruptcy Amid Privacy Concerns and Leadership Changes

23andMe Board Resigns Amid CEO's Privatization Push

AlloVir, Inc. Faces Multiple Class Action Lawsuits Over Securities Fraud Allegations